Check-Cap Ltd
MBAINasdaq
$1.00
0.0%Jul 17 close · end-of-day
Price
1Y↑ +28.4%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$6.2M
Enterprise Value
-$25.8M
P/E
1.5
P/S
—
P/B
0.2
EV/EBITDA
—
PEG
—
FCF Yield
—
Dividend Yield
—
Revenue (TTM)
—
Net Income (TTM)
$4.1M
Free Cash Flow (TTM)
—
Gross Margin
—
Operating Margin
—
Net Margin
—
ROE
13.7%
ROIC
—
Debt / Equity
—
Net Cash
$32.1M
Return 1Y
+29.9%
Company profile
Check-Cap Ltd. engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps. The company was incorporated in 2004 and is based in Isfiya, Israel.
- CEO
- Alex Ovadia
- Sector
- Manufacturing
- Industry
- Medical Equipment
- Employees
- 80
- Website
- check-cap.com
Earnings
MBAI Q2 2023 Earnings
Period ends 2023-06-30
MetricActualYoY
Revenue——
Diluted EPS$1.18↑ +43.9%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — |
| Operating income | -$13.9M | -$17.3M | -$20.0M | -$19.3M | -$9.5M | -$2.4M |
| Net income | -$13.8M | -$17.2M | -$19.1M | -$17.6M | -$25.1M | $4.1M |
| Diluted EPS | $9.01 | $4.14 | $3.37 | -$3.00 | -$4.30 | $0.66 |
| Operating cash flow | -$13.1M | -$16.3M | -$18.7M | -$17.0M | -$8.0M | -$46,000.00 |
| Free cash flow | -$13.5M | -$17.3M | -$19.2M | -$17.0M | — | — |
| Gross margin | — | — | — | — | — | — |
| Operating margin | — | — | — | — | — | — |
| Net margin | — | — | — | — | — | — |
| Line item | Q2 '21 | Q2 '21 | Q2 '22 | Q2 '22 | Q2 '23 | Q2 '23 |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — |
| Operating income | — | -$3.9M | — | -$4.9M | — | -$7.4M |
| Net income | -$3.6M | -$3.9M | -$5.8M | -$4.8M | -$4.4M | -$6.9M |
| Diluted EPS | — | $0.06 | — | $0.82 | — | $1.18 |
| Operating cash flow | — | — | — | — | — | — |
| Free cash flow | — | — | — | — | — | — |
| Gross margin | — | — | — | — | — | — |
| Operating margin | — | — | — | — | — | — |
| Net margin | — | — | — | — | — | — |
Company news
Jun 29, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
No insider transactions in the last 12 months.
No insider transactions on file.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.